ArticleThe Saudi dental journal2026
Quercus persica lozenges versus placebo for reducing gag reflex severity in adult dental patients: a randomized double-blind controlled trial.
Article in The Saudi dental journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The gag reflex is a common challenge during dental procedures, often impairing clinical performance and causing patient discomfort. While pharmacological interventions are commonly employed, they can lead to adverse effects or be poorly tolerated. Herbal alternatives with local mucosal activity have gained increasing attention as potentially safer adjuncts. Quercus persica (Persian oak), rich in tannins, exhibits astringent and mucosal-desensitizing properties that may contribute to reducing gag reflex sensitivity. To evaluate the efficacy of a Quercus persica extract lozenge in reducing gag reflex severity in adult dental patients. In this randomized, double-blind, placebo-controlled clinical trial, 80 adult patients with a documented history of gag reflex were enrolled and equally allocated (1:1) into intervention and placebo groups (n = 40 each). Participants received either a 1-gram lozenge containing 200 mg of Quercus persica extract or an identical placebo. Gag reflex severity was assessed before and after intervention using a standardized 4-point ordinal scale across five intraoral regions. The primary outcome was the change in overall gag reflex score. Baseline demographic characteristics were comparable between the two groups. The Quercus persica group exhibited a significant reduction in overall gag reflex score (from 5.98 ± 2.26 to 1.38 ± 1.72; p = 0.001), in the placebo group (from 5.83 ± 2.01 to 5.10 ± 2.10; p = 0.002). Between-group comparison confirmed a significantly greater reduction in the intervention group (p < 0.001). Region-specific analysis revealed the greatest improvements in the soft palate and tonsillar regions, with mean reductions of 1.75 and 1.73 points, respectively (p < 0.001). Quercus persica lozenges were associated with a statistically significant reduction in gag reflex severity compared to placebo, particularly in highly sensitive intraoral regions. These findings suggest that Quercus persica may serve as a potential adjunctive approach for gag reflex management; however, conclusions should be interpreted with caution given the short-term assessment, and further studies are required to evaluate long-term efficacy, safety, and patient-reported outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.